Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Amplia Therapeutics Limited has announced the application for quotation of 1,821,508 new fully paid ordinary securities on the ASX under the code ATX, effective from July 17, 2024. The application signifies potential growth and investment opportunities for stakeholders in the biotechnological sector.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.
